Twelve Months of Receipts: An Honest Accounting of One Family's Cross-Border Prescription Habit

Most claims about prescription savings come with an asterisk the size of a dinner plate. So when the Hendersons of Columbus, Ohio — a retired couple managing hypertension, high cholesterol, and type 2 diabetes — agreed to share twelve months of pharmacy records with us, we asked for everything: order confirmations, bank statements, shipping notices, and the receipts from their physician visits. What follows is the arithmetic most advertisements leave out.

The Starting Point: What the Local Shelf Cost Them

Before their first order in January, the Hendersons filled three maintenance prescriptions at a national chain pharmacy in Franklin County. Using their Medicare Part D plan plus a manufacturer discount on the diabetes medication, their monthly out-of-pocket total came to $187.40. Annualized, that is $2,248.80 — the baseline against which everything else must be measured.

This baseline matters. Any comparison that starts from a pharmacy's undiscounted sticker price will inflate the apparent savings. The honest comparison is against what you would actually pay at home, coupon in hand.

The Canadian Ledger, Line by Line

Over the year, the Hendersons placed four orders with a licensed Canadian pharmacy, each covering a 90-day supply of all three medications. Here is the complete accounting:

• Medication cost: $612.00 across four orders, averaging $153.00 per 90-day cycle.
• Shipping: $68.00 total, at $17.00 per order.
• Currency conversion fees: Their bank charged a 2.5% foreign transaction fee on each charge, adding roughly $15.30 annually.
• Physician visits: Their prescriptions required two office visits during the year at a copay of $30 each — costs they would have incurred regardless, but worth stating plainly.

The true annual total came to $725.30, against a domestic baseline of $2,248.80. Net savings: $1,523.50, or roughly 68%.

Where the Math Could Have Gone Wrong

That figure is strong, but it is not automatic. Three variables could have eroded it substantially.

Order frequency. Had the Hendersons ordered monthly instead of quarterly, shipping alone would have added $170 to their costs — still a win, but a narrower one. Consolidating refills into 90-day supplies is the single biggest lever in cross-border economics.

Generic availability at home. Two of their three medications are available as generics in the United States at aggressive discount-card prices. We re-ran their numbers using the best local discount card rates we could find for all three drugs: the annual total dropped to $1,410. The Canadian advantage shrank from 68% to about 49% — real, but far less dramatic. Households whose medications are older generics may find the domestic aisle competitive.

The exchange rate. The Canadian dollar traded between roughly $0.72 and $0.75 USD during the year, which worked in their favour. A stronger loonie would trim margins modestly; it is a variable worth watching but rarely a decisive one.

When Ordering North Makes Sense — and When It Doesn't

The Hendersons' ledger suggests a straightforward rule of thumb. Ordering from a licensed Canadian pharmacy delivers its clearest advantage when three conditions align: the medication is a brand-name or newly generic product still priced high in the U.S. market; orders can be consolidated into multi-month supplies; and the household's insurance imposes a coverage gap or high coinsurance tier that discount cards cannot touch.

Conversely, the discount card wins when a drug is a widely distributed generic, when quantities needed are small, or when a prescription changes frequently and stability of supply matters more than price.

The Paper Trail Is the Point

What struck us most was not the savings — it was how legible the process became once the receipts were laid side by side. The Hendersons could point to every dollar: what the medication cost, what the border crossing added, what the bank skimmed in fees. That transparency is itself a safety feature. A pharmacy that cannot produce a clear, itemized receipt with a licensed pharmacist's information attached has failed a test that costs nothing to pass.

For American households weighing the same decision, the lesson is unglamorous but reliable: keep your own ledger for one quarter, compare it honestly against your best domestic price, and let the arithmetic — not the advertising — make the call.